Publications by authors named "Volkmar Mueller"

Claim this Profile
H
HER2CLIMB-05: A Phase 3 Study of Tucatinib Versus Placebo in Combination with Trastuzumab and Pertuzumab as First-line Maintenance Therapy for HER2+ Metastatic Breast Cancer.
Veronique Dieras, Giuseppe Curigliano, Miguel Martin, Florence Lerebours, Junji Tsurutani, Volkmar Mueller

J Clin Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AGO Breast Commission recommendations for the surgical therapy of breast cancer: Working Group on Gynecologic Cancers (AGO) update 2025.
Toralf Reimer, Thorsten Kuehn, Volkmar Mueller, Nina Ditsch, Tanja Fehm

Eur J Surg Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
6
6th and 7th International consensus guidelines for the management of advanced breast cancer (ABC guidelines 6 and 7).
Fatima Cardoso, Shani Paluch-Shimon, Eva Schumacher-Wulf, Leonor Matos, Karen Gelmon, Volkmar Mueller

Breast· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Lapatinib in Patients with HER2-Negative Metastatic Breast Cancer and HER2-Positive Circulating Tumor Cells-The DETECT III Clinical Trial.
Tanja Fehm, Volkmar Mueller, Maggie Banys-Paluchowski, Peter A Fasching, Thomas W P Friedl, Lothar Mueller

Clin Chem· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial.
Peter A Fasching, Christopher Szeto, Carsten Denkert, Stephen Benz, Karsten Weber, Volkmar Mueller

Clin Cancer Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value.
André Franken, Annika Kraemer, Alicia Sicking, Meike Watolla, Mahdi Rivandi, Volkmar Mueller

Br J Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a short instrument for measuring health-related quality of life in oncological patients in routine care (HELP-6): an observational study.
Theresa Schrage, Mirja Görlach, Christian Stephan Betz, Carsten Bokemeyer, Nicolaus Kröger, Volkmar Mueller

Front Psychol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tucatinib vs Placebo, Both in Combination With Trastuzumab and Capecitabine, for Previously Treated ERBB2 (HER2)-Positive Metastatic Breast Cancer in Patients With Brain Metastases: Updated Exploratory Analysis of the HER2CLIMB Randomized Clinical Trial.
Nancy U Lin, Rashmi K Murthy, Vandana Abramson, Carey Anders, Thomas Bachelot, Volkmar Mueller

JAMA Oncol· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis-Results from the Adjuvant SUCCESS A Trial.
Elisabeth K Trapp, Peter A Fasching, Tanja Fehm, Andreas Schneeweiss, Volkmar Mueller

Cancers (Basel)· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of Enhanced Recovery after Surgery (ERAS) pathways with regard to perioperative outcome in patients with ovarian cancer.
Susanne Reuter, Linn Woelber, Constantin C Trepte, Daniel Perez, Antonia Zapf, Volkmar Mueller

Arch Gynecol Obstet· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEGF-C serum level is associated with response to bevacizumab maintenance therapy in primary ovarian cancer patients.
Yi Ding, Leticia Oliveira-Ferrer, Eike Vettorazzi, Karen Legler, Karin Milde-Langosch, Volkmar Mueller

PLoS One· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Comprehensive Molecular Analysis of in Vivo Isolated EpCAM-Positive Circulating Tumor Cells in Breast Cancer.
Areti Strati, Martha Zavridou, Galatea Kallergi, Eleni Politaki, Andra Kuske, Volkmar Mueller

Clin Chem· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preservation of quality of life in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer treated with tucatinib or placebo when added to trastuzumab and capecitabine (HER2CLIMB trial).
Volkmar Mueller, Andrew Wardley, Elisavet Paplomata, Erika Hamilton, Amelia Zelnak

Eur J Cancer· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Demand for integrative medicine among women with breast and gynecological cancer: a multicenter cross-sectional study in Southern and Northern Germany.
Donata Grimm, Sofia Mathes, Linn Woelber, Caroline Van Aken, Barbara Schmalfeldt, Volkmar Mueller

Arch Gynecol Obstet· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Therapeutic Approaches in Vulvar Squamous Cell Cancer (VSCC): Case Series and Review of the Literature.
Linn Woelber, Sabrina Mathey, Katharina Prieske, Sascha Kuerti, Christoph Hillen, Volkmar Mueller

Oncol Res· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intracranial Efficacy and Survival With Tucatinib Plus Trastuzumab and Capecitabine for Previously Treated HER2-Positive Breast Cancer With Brain Metastases in the HER2CLIMB Trial.
Nancy U Lin, Virginia Borges, Carey Anders, Rashmi K Murthy, Elisavet Paplomata, Volkmar Mueller

J Clin Oncol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Short Instrument for Measuring Health-Related Quality of Life in Oncological Patients for Clinical Use: Protocol for an Observational Study.
Theresa Schrage, Mirja Görlach, Christian Stephan Betz, Carsten Bokemeyer, Nicolaus Kröger, Volkmar Mueller

JMIR Res Protoc· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebral metastasis in recurrent squamous cell carcinoma of the vulva: case report and review of the literature.
Anna Jaeger, Maxine Biermann, Katharina Prieske, Donata Grimm, Astrid Grottke, Volkmar Mueller

Arch Gynecol Obstet· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of ESR1 Mutations in Single Circulating Tumor Cells on Estrogen Deprivation Therapy but Not in Primary Tumors from Metastatic Luminal Breast Cancer Patients.
André Franken, Ellen Honisch, Florian Reinhardt, Franziska Meier-Stiegen, Liwen Yang, Volkmar Mueller

J Mol Diagn· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Di Cosimo, Torri, and Porcu.
Elisabeth Trapp, Wolfgang Janni, Christian Schindlbeck, Julia Jückstock, Ulrich Andergassen, Volkmar Mueller

J Natl Cancer Inst· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis.
Elisabeth Trapp, Wolfgang Janni, Christian Schindlbeck, Julia Jückstock, Ulrich Andergassen, Volkmar Mueller

J Natl Cancer Inst· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of PapilloCheck and Linear Array to Detect and Differentiate Human Papillomaviruses in Cervical and Tonsillar Smears from Females with Cervical Intraepithelial Lesions.
Donata Grimm, Linn Woelber, Katharina Prieske, Barbara Schmalfeldt, Sascha Kürti, Volkmar Mueller

Eur J Microbiol Immunol (Bp)· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Participation of elderly gynecological cancer patients in clinical trials.
Katharina Prieske, Fabian Trillsch, Gülten Oskay-Özcelik, Radoslav Chekerov, Christiane Bleich, Volkmar Mueller

Arch Gynecol Obstet· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis.
François-Clément Bidard, Stefan Michiels, Sabine Riethdorf, Volkmar Mueller, Laura J Esserman

J Natl Cancer Inst· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Predictive Significance of Metastasis-Associated in Colon Cancer-1 (MACC1) in Primary Breast Cancer.
Jasminka Prguda-Mujic, Karin Milde-Langosch, Volkmar Mueller, Mirza Suljagic, Jozo Coric

Ann Clin Lab Sci· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis